VC firm
Forepont Capital Partners
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- New York, NY, United States
- Founded
- 2017
- Assets under management
- $89.1MForm ADV private fund GAV, as of 2026-01-13Source (opens in a new tab)
- Funds
- 2
- Legal name
- Forepont Capital LLC
Claim, correct or request removal
Record updated 29 September 2026
About
We are a venture capital firm established in 2017 in New York. We are present in New York, Palo Alto, London, Paris and Dubai.
Investment approach
- Thesis
- AI to advance neuroscience, with a primary focus on the brain – Brain AI. Brain AI to transform healthcare and industries beyond – including safety, education, defense and device control. Biological frameworks to boost AI performance, efficiency, and develop new capabilities.Source (opens in a new tab)
- Takes board seats
- Sometimes
- Board policy
- We retain a board position in most of our portfolio companies.
- Ownership target
- Our positions are sized to maintain influence on the board.
- Investing status notes
- We invest in early-stage companies before the inflection point with the potential to improve the life of millions.
Funds
- FOREPONT CAPITAL PARTNERS FUND 2, L.P.
- Main fund
- FOREPONT CAPITAL PARTNERS FUND II FPCI
- Main fund
SEC registration
- Registered adviser
- FOREPONT CAPITAL LLC
- CRD number
- 308323 (opens in a new tab)
- SEC file number
- 802-135325
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $89.1Mas of 2026-01-13
- Private funds reported
- 2
- Principal office
- WHITE PLAINS, NY, United States
Locations
- Headquarters
- New York, NY, United States
Loading relationship preview